These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25463093)

  • 1. Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease.
    Krychtiuk KA; Kastl SP; Pfaffenberger S; Pongratz T; Hofbauer SL; Wonnerth A; Katsaros KM; Goliasch G; Gaspar L; Huber K; Maurer G; Dostal E; Oravec S; Wojta J; Speidl WS
    Atherosclerosis; 2014 Dec; 237(2):589-96. PubMed ID: 25463093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of small dense LDL serum levels and circulating monocyte subsets in stable coronary artery disease.
    Krychtiuk KA; Kastl SP; Pfaffenberger S; Lenz M; Hofbauer SL; Wonnerth A; Koller L; Katsaros KM; Pongratz T; Goliasch G; Niessner A; Gaspar L; Huber K; Maurer G; Dostal E; Wojta J; Oravec S; Speidl WS
    PLoS One; 2015; 10(4):e0123367. PubMed ID: 25849089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation Between High-Density Lipoprotein and Monocyte Subsets in Patients with Stable Coronary Heart Disease.
    Jiang S; Li D; Li J; An Y
    Med Sci Monit; 2015 Jun; 21():3129-35. PubMed ID: 26474031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a).
    Krychtiuk KA; Kastl SP; Hofbauer SL; Wonnerth A; Goliasch G; Ozsvar-Kozma M; Katsaros KM; Maurer G; Huber K; Dostal E; Binder CJ; Pfaffenberger S; Oravec S; Wojta J; Speidl WS
    J Clin Lipidol; 2015; 9(4):533-41. PubMed ID: 26228671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease.
    Czepluch FS; Kuschicke H; Dellas C; Riggert J; Hasenfuss G; Schäfer K
    J Intern Med; 2014 Feb; 275(2):144-54. PubMed ID: 24118494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower HDL-C levels are associated with higher expressions of CD16 on monocyte subsets in coronary atherosclerosis.
    Xiang Y; Liang B; Zhang X; Zheng F
    Int J Med Sci; 2020; 17(14):2171-2179. PubMed ID: 32922178
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) are associated with monocyte subsets in patients with stable coronary artery disease.
    Krychtiuk KA; Lenz M; Hohensinner P; Distelmaier K; Schrutka L; Kastl SP; Huber K; Dostal E; Oravec S; Hengstenberg C; Wojta J; Speidl WS
    J Clin Lipidol; 2021; 15(3):512-521. PubMed ID: 33789832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis.
    Shantsila E; Tapp LD; Wrigley BJ; Pamukcu B; Apostolakis S; Montoro-García S; Lip GY
    Atherosclerosis; 2014 May; 234(1):4-10. PubMed ID: 24583499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.
    Rogacev KS; Cremers B; Zawada AM; Seiler S; Binder N; Ege P; Große-Dunker G; Heisel I; Hornof F; Jeken J; Rebling NM; Ulrich C; Scheller B; Böhm M; Fliser D; Heine GH
    J Am Coll Cardiol; 2012 Oct; 60(16):1512-20. PubMed ID: 22999728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease.
    Rogacev KS; Zawada AM; Emrich I; Seiler S; Böhm M; Fliser D; Woollard KJ; Heine GH
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2120-7. PubMed ID: 25060791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between high density lipoprotein and monocyte subpopulations among stable coronary atherosclerotic heart disease patients.
    Yang RH; Liu YF; Wang XJ; Liang JG; Liu JC
    Int J Clin Exp Med; 2015; 8(9):16969-77. PubMed ID: 26629252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte-platelet complexes on CD14/CD16 monocyte subsets: relationship with ApoA-I levels. A preliminary study.
    Boudjeltia KZ; Brohee D; Piro P; Nuyens V; Ducobu J; Kherkofs M; Van Antwerpen P; Cauchie P; Remacle C; Vanhaeverbeek M
    Cardiovasc Pathol; 2008; 17(5):285-8. PubMed ID: 18402816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating CD14+CD16+ monocyte subsets as biomarkers of the severity of coronary artery disease in patients with stable angina pectoris.
    Ozaki Y; Imanishi T; Taruya A; Aoki H; Masuno T; Shiono Y; Komukai K; Tanimoto T; Kitabata H; Akasaka T
    Circ J; 2012; 76(10):2412-8. PubMed ID: 22785372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating non-HDL-C levels were more relevant to atherogenic lipoprotein subfractions compared with LDL-C in patients with stable coronary artery disease.
    Zhu CG; Zhang Y; Xu RX; Li S; Wu NQ; Guo YL; Sun J; Li JJ
    J Clin Lipidol; 2015; 9(6):794-800. PubMed ID: 26687700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of EMMPRIN (CD147) on monocyte subsets in patients with symptomatic coronary artery disease.
    Sturhan H; Ungern-Sternberg SN; Langer H; Gawaz M; Geisler T; May AE; Seizer P
    Thromb Res; 2015 Jun; 135(6):1160-4. PubMed ID: 25824988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population.
    Coen PM; Flynn MG; Markofski MM; Pence BD; Hannemann RE
    Metabolism; 2010 Dec; 59(12):1775-83. PubMed ID: 20580035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels.
    Schlitt A; Heine GH; Blankenberg S; Espinola-Klein C; Dopheide JF; Bickel C; Lackner KJ; Iz M; Meyer J; Darius H; Rupprecht HJ
    Thromb Haemost; 2004 Aug; 92(2):419-24. PubMed ID: 15269840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of short-term low-dose atorvastatin on low-density lipoprotein and high-density lipoprotein subfraction phenotype.
    Xu RX; Guo YL; Li XL; Li S; Li JJ
    Clin Exp Pharmacol Physiol; 2014 Jul; 41(7):475-81. PubMed ID: 24739131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The "Intermediate" CD14
    Wildgruber M; Aschenbrenner T; Wendorff H; Czubba M; Glinzer A; Haller B; Schiemann M; Zimmermann A; Berger H; Eckstein HH; Meier R; Wohlgemuth WA; Libby P; Zernecke A
    Sci Rep; 2016 Dec; 6():39483. PubMed ID: 27991581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosuvastatin-induced high-density lipoprotein changes in patients who underwent percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.
    Yun KH; Shin SN; Ko JS; Rhee SJ; Kim NH; Oh SK; Jeong JW
    J Cardiol; 2012 Nov; 60(5):383-8. PubMed ID: 22884684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.